Synthesis and biological evaluation of 1-(2-hydroxy-3-phenyloxypropyl)piperazine derivatives as T-type calcium channel blockers

Bioorganic & Medicinal Chemistry Letters
2013.0

Abstract

To obtain selective and potent inhibitor for T-type calcium channel by ligand based drug design, 2-hydroxy-3-phenoxypropyl piperazine derivatives were synthesized and evaluated for in vitro activities. Compound 6m and 6q showed high selectivity over hERG channel (IC50 ratio of hERG/α1G6m=8.5, 6q=18.38) and they were subjected to measure pharmacokinetics profiles. Among them compound 6m showed an excellent pharmacokinetic profile in rats.

Knowledge Graph

Similar Paper

Synthesis and biological evaluation of 1-(2-hydroxy-3-phenyloxypropyl)piperazine derivatives as T-type calcium channel blockers
Bioorganic & Medicinal Chemistry Letters 2013.0
Synthesis and biological evaluation of 4-piperidinecarboxylate and 4-piperidinecyanide derivatives for T-type calcium channel blockers
Bioorganic & Medicinal Chemistry Letters 2011.0
Synthesis and biological evaluation of 1,4-diazepane derivatives as T-type calcium channel blockers
Bioorganic & Medicinal Chemistry Letters 2010.0
Synthesis and biological evaluation of oxazole derivatives as T-type calcium channel blockers
Bioorganic & Medicinal Chemistry Letters 2010.0
Facile synthesis and biological evaluation of 3,3-diphenylpropanoyl piperazines as T-type calcium channel blockers
Bioorganic & Medicinal Chemistry Letters 2011.0
Synthesis and evaluation of α,α′-disubstituted phenylacetate derivatives for T-type calcium channel blockers
Bioorganic & Medicinal Chemistry Letters 2008.0
Lead discovery and optimization of T-type calcium channel blockers
Bioorganic & Medicinal Chemistry 2007.0
Novel T-type calcium channel blockers: Dioxoquinazoline carboxamide derivatives
Bioorganic & Medicinal Chemistry 2007.0
Design, synthesis, and biological evaluation of 1,3-dioxoisoindoline-5-carboxamide derivatives as T-type calcium channel blockers
Bioorganic & Medicinal Chemistry Letters 2007.0
Synthesis and biological activity of 3,4-dihydroquinazolines for selective T-type Ca2+ channel blockers
Bioorganic & Medicinal Chemistry Letters 2005.0